Why LumiraDx Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Avi Kapoor
LumiraDx Limited (NASDAQ:LMDX) shares dropped by 20% in pre-market trading following the announcement of selling its point-of-care technology platform to Roche. Other stocks experienced significant movements in pre-market trading, with various companies listed as gainers and losers based on their recent performance and news.
January 02, 2024 | 1:08 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
LumiraDx shares fell sharply by 19.7% in pre-market trading due to the sale of its point-of-care technology platform to Roche.
The sharp decline in LumiraDx's share price is likely due to investor concerns over the sale of a significant part of its business to Roche, which may affect future revenue and growth prospects.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100